Literature DB >> 954793

Continuous low-dose cyclophosphamide (NSC-26271) therapy in advanced ovarian cancer.

C Mangioni, G Bolis, N Natale, L Morasca.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 954793     DOI： 10.1016/0014-2964(76)90172-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  2 in total

1.  Pharmacokinetics of cyclophosphamide after prolonged low dose treatment in ovarian cancer patients.

Authors:  M D'Incalci; T Facchinetti; G Bolis; C Mangioni; L Morasca
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

2.  Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer. A randomized clinical study.

Authors:  G Bolis; G Bortolozzi; G Carinelli; M D'Incalci; F Gramellini; L Morasca; C Mangioni
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.